Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3037938
Max Phase: Preclinical
Molecular Formula: C54H58Cl2N4O4
Molecular Weight: 827.08
Molecule Type: Small molecule
Associated Items:
ID: ALA3037938
Max Phase: Preclinical
Molecular Formula: C54H58Cl2N4O4
Molecular Weight: 827.08
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C[N+]23CC[C@@]45c6ccccc6N6[C@@H]7OCC=C8C[N+]9(Cc%10ccc(OC)cc%10)CC[C@]%10%11c%12ccccc%12N([C@@H]%12OCC=C(C2)[C@H](C[C@@H]43)[C@@H]%12[C@H]65)[C@H]%10[C@H]7[C@H]8C[C@@H]%119)cc1.[Cl-].[Cl-]
Standard InChI: InChI=1S/C54H58N4O4.2ClH/c1-59-37-15-11-33(12-16-37)29-57-23-21-53-41-7-3-5-9-43(41)55-49(53)47-39(27-45(53)57)35(31-57)19-25-61-51(47)56-44-10-6-4-8-42(44)54-22-24-58(30-34-13-17-38(60-2)18-14-34)32-36-20-26-62-52(55)48(50(54)56)40(36)28-46(54)58;;/h3-20,39-40,45-52H,21-32H2,1-2H3;2*1H/q+2;;/p-2/t39-,40-,45-,46-,47+,48+,49-,50-,51+,52+,53+,54+,57?,58?;;/m0../s1
Standard InChI Key: DOCLEVBRLZJPHB-DUNHHUDBSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 827.08 | Molecular Weight (Monoisotopic): 826.4447 | AlogP: 7.71 | #Rotatable Bonds: 6 |
Polar Surface Area: 43.40 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -0.80 | CX LogD: -0.80 |
Aromatic Rings: 4 | Heavy Atoms: 62 | QED Weighted: 0.15 | Np Likeness Score: 0.98 |
1. Zlotos DP, Buller S, Stiefl N, Baumann K, Mohr K.. (2004) Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems., 47 (14): [PMID:15214783] [10.1021/jm0311341] |
Source(1):